{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/chronic-kidney-disease/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"e9caee39-e4d7-55ea-bba5-d1bfb037fab3","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field a301b108-32a2-4afd-91a5-66f8ce3a099e --><h2>Update</h2><!-- end field a301b108-32a2-4afd-91a5-66f8ce3a099e -->","summary":null,"htmlStringContent":"<!-- begin item 8c662934-10b0-4edf-a698-2707965fe7be --><!-- end item 8c662934-10b0-4edf-a698-2707965fe7be -->","topic":{"id":"cf2598e6-fd50-5f3b-8ae0-aad8ebd19ed8","topicId":"ae266062-cc1b-44e2-8118-44e1890750e3","topicName":"Chronic kidney disease","slug":"chronic-kidney-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"5036566c-74da-5f5a-8ad0-52200f66bacc","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5b4e7fb9-e75e-5183-b93f-5121d902b8aa","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"75479619-9bb3-51b1-8d45-322a0183327c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"85bf4dec-7d92-5c07-9468-68fd460fa54c","slug":"changes","fullItemName":"Changes"},{"id":"e9caee39-e4d7-55ea-bba5-d1bfb037fab3","slug":"update","fullItemName":"Update"}]},{"id":"94be5ea4-6a52-53bd-9cff-cbc58599fb38","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"af9d912d-8cc7-598f-90cf-201a0152486f","slug":"goals","fullItemName":"Goals"},{"id":"e04a2acd-d3aa-5b29-afe8-4ff8a5cf2527","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c36c8ae1-59b3-5370-8b7b-c879c1c25d17","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1bb64e97-bb95-5733-ba72-d5da80477d5b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0cefa383-4a3f-5e37-8c1d-0cc7b2ba971c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c308ef71-7be3-579d-9b92-dd1e9164c74d","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"34f1f543-1b43-52aa-91e6-43d392ace4b2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"420f2db7-0bb3-5f08-a35d-671ffd9e83db","slug":"definition","fullItemName":"Definition"},{"id":"f36e5c98-76d5-563f-b7e3-a8e580d8edda","slug":"causes","fullItemName":"Causes"},{"id":"16745b88-79f5-5576-a0a4-704c8cb342e4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"82584375-f9fb-5690-9fe3-f2fb2586f2de","slug":"complications","fullItemName":"Complications"},{"id":"6ddacff5-19b6-5342-b340-25aecbf26dbd","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"00dbd4ad-decc-5bde-b4a3-2599d730c702","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cdd9f22d-7a2f-5fd6-a9e1-199b0c3ffdfa","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c6b6c8c3-633d-5062-9804-7b6711e7ddcd","slug":"assessment","fullItemName":"Assessment"},{"id":"3878fa85-9973-5158-8407-20d64dbf148d","slug":"initial-investigations","fullItemName":"Initial investigations"}]},{"id":"579baee5-96e6-5639-a5ee-7dc30540dc8f","fullItemName":"Management","slug":"management","subChapters":[{"id":"07ec0bcd-8fb7-5ae7-87fd-2ff471574c5c","slug":"management-of-chronic-kidney-disease","fullItemName":"Scenario: Management of chronic kidney disease"},{"id":"44ceaa7d-a91b-5472-a7ab-e4bc448067ad","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"b0158ce5-7a78-50df-8843-ded7d59d08e3","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a270530d-7db1-5b03-a1d8-8ff38e242ab9","slug":"ace-inhibitors-aiiras","fullItemName":"ACE-inhibitors and AIIRAs"}]},{"id":"50985320-3b22-5997-85d2-680285318de6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"168ee77d-eb0d-52d8-a32b-4bda877d21f0","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c8ca80a7-ccf2-5a42-9b8e-72783e1f2131","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fe26a3ba-fa1b-5c97-8a08-e1f7d193447a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"854a26b2-4877-59ae-863e-99abcbcad667","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0af4d212-648e-5a4d-ad67-b1874a49688e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f180e32d-a855-558d-b666-d4c6804afe04","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ba009e6c-4065-55da-b6c5-bd179af81374","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"75479619-9bb3-51b1-8d45-322a0183327c","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"109db48e-59a4-5645-9673-aaa61eddf353","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field acdb11a4-18ee-40ad-a0f9-1db04bc0c05a --><h3>New evidence</h3><!-- end field acdb11a4-18ee-40ad-a0f9-1db04bc0c05a -->","summary":null,"htmlStringContent":"<!-- begin item 856b1051-b0d3-4773-8841-180c126d9c4b --><!-- begin field 8abec5ef-2032-44bb-919f-fb12af988618 --><h3>Evidence-based guidelines</h3><!-- end field 8abec5ef-2032-44bb-919f-fb12af988618 --><!-- begin field 1e099ea1-aeea-4889-973c-e69c05fb7b80 --><ul><li>Multicultural renal resources working party of the BDA Renal Nutrition Group (2019) <em>Development of Black and minority ethnic (BME) patient-centred dietary resources to improve hyperkalaemia in chronic kidney disease patients. </em>National Institute for Health and Care Excellence. [<a href=\"https://www.nice.org.uk/sharedlearning/development-of-black-and-minority-ethnic-bme-patient-centred-dietary-resources-to-improve-hyperkalaemia-in-chronic-kidney-disease-patients\" data-hyperlink-id=\"579e80b1-cecb-45a4-b837-aa3f00df6a53\">Free Full-text</a>]</li></ul><!-- end field 1e099ea1-aeea-4889-973c-e69c05fb7b80 --><!-- begin field 5d53c029-f982-4a75-a8e0-f30b4e117adc --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 5d53c029-f982-4a75-a8e0-f30b4e117adc --><!-- begin field c8522a13-9dd5-4bed-a269-b09f130bd185 --><p>No new HTAs have been published since 1 February 2019.</p><!-- end field c8522a13-9dd5-4bed-a269-b09f130bd185 --><!-- begin field 4ce3e6db-52c7-410d-8af1-87843eed4ab9 --><h3>Economic appraisals</h3><!-- end field 4ce3e6db-52c7-410d-8af1-87843eed4ab9 --><!-- begin field d9c585b3-1541-49c0-a752-14c3bd6bd2a9 --><p>No new economic appraisals have been published since 1 February 2019.</p><!-- end field d9c585b3-1541-49c0-a752-14c3bd6bd2a9 --><!-- begin field b03a1e68-225b-40f1-baf6-7a498e192296 --><h3>Systematic reviews and meta-analyses</h3><!-- end field b03a1e68-225b-40f1-baf6-7a498e192296 --><!-- begin field 7554b2bd-c384-4498-bdab-97261195601c --><ul><li>Chung, E.Y.M., Ruospo, M., Natale, P., et al. (2020) <em>Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.</em> Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"c4a6d71b-a433-41d9-83da-ac6b00bfb442\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007004.pub4/full\" data-hyperlink-id=\"fd3bb66f-88cf-4b2e-a069-ac6b00bfb51f\">Free Full-text</a>]</li></ul><!-- end field 7554b2bd-c384-4498-bdab-97261195601c --><!-- begin field 0b22ddc9-f495-4c5e-87d2-12b586c2f3fa --><h3>Primary evidence</h3><!-- end field 0b22ddc9-f495-4c5e-87d2-12b586c2f3fa --><!-- begin field e3458265-9ecd-43c5-bde2-7f100174bfa6 --><p>No randomized controlled trials in the major journals since 1 February 2019.</p><!-- end field e3458265-9ecd-43c5-bde2-7f100174bfa6 --><!-- end item 856b1051-b0d3-4773-8841-180c126d9c4b -->","subChapters":[]},{"id":"09845a51-6f79-5fe4-ab43-bc824084229f","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 3e8a564b-cf22-445c-8503-bdeb67684f6e --><h3>New policies</h3><!-- end field 3e8a564b-cf22-445c-8503-bdeb67684f6e -->","summary":null,"htmlStringContent":"<!-- begin item 9e6c4f95-1a24-4610-99ab-54b5fdd33a9d --><!-- begin field d7f64668-4624-43c8-921f-25e9519b9cc6 --><p>No new national policies or guidelines since 1 February 2019.</p><!-- end field d7f64668-4624-43c8-921f-25e9519b9cc6 --><!-- end item 9e6c4f95-1a24-4610-99ab-54b5fdd33a9d -->","subChapters":[]},{"id":"e9050ecf-1cb2-5cd8-b21e-dca77d10b374","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 9b9b34df-bd52-4b77-ba1a-b59728ecddd8 --><h3>New safety alerts</h3><!-- end field 9b9b34df-bd52-4b77-ba1a-b59728ecddd8 -->","summary":null,"htmlStringContent":"<!-- begin item 2419a2bd-9cee-4ae4-bea1-633489bc94e8 --><!-- begin field 605373d3-e55a-4045-a163-bf3b219ac5a2 --><p>No new safety alerts have been issued since 1 February 2019.</p><!-- end field 605373d3-e55a-4045-a163-bf3b219ac5a2 --><!-- end item 2419a2bd-9cee-4ae4-bea1-633489bc94e8 -->","subChapters":[]},{"id":"a2a06a1b-0bb9-5737-8ff8-0829312b51ad","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 2ea80d18-5926-4fde-ac74-116e24c17eda --><h3>Changes in product availability</h3><!-- end field 2ea80d18-5926-4fde-ac74-116e24c17eda -->","summary":null,"htmlStringContent":"<!-- begin item d7a21ad2-7733-4bd6-8e0e-33a448c17430 --><!-- begin field 5bd866e3-4245-4d07-bcd8-98be938310c6 --><p>No changes in product availability since 1 February 2019.</p><!-- end field 5bd866e3-4245-4d07-bcd8-98be938310c6 --><!-- end item d7a21ad2-7733-4bd6-8e0e-33a448c17430 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}